AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CETRIAXONE
4 registrations across 3 African markets— 3 active
Markets with CETRIAXONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| C-TRI 1 G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| CEFTRIX 1000MG SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | FCARE PHARMA LIMITED | active | — |
| STERICEF perfusion / 1g | 🇸🇳Senegal | UNITED BIOTECH | active | — |
| STERICEF perfusion / 1g | 🇸🇳Senegal | UNITED BIOTECH | active | — |
CETRIAXONE in Africa — Regulatory Overview
CETRIAXONE is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.